We are live on ! Find out more
BNR

Burning Rock Biotech
BNR

47 hedge funds and large institutions have $426M invested in Burning Rock Biotech in 2020 Q2 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1.87% more ownership

Funds ownership: 0% → 1.87% (+1.9%)

Holders
47
Holders Change
+47
Holders Change %
–
% of All Funds
0.96%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
47
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$130M
2
MICM
Matthews International Capital Management
California
+$49.7M
3
CC
Casdin Capital
New York
+$47.4M
4
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
+$23.3M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$21.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$128M +$130M +474,607 New
MICM
2
Matthews International Capital Management
California
$49M +$49.7M +181,257 New
CC
3
Casdin Capital
New York
$46.7M +$47.4M +173,079 New
Canada Pension Plan Investment Board
4
Canada Pension Plan Investment Board
Ontario, Canada
$23M +$23.3M +85,000 New
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$21.3M +$21.6M +78,890 New
Baillie Gifford & Co
6
Baillie Gifford & Co
United Kingdom
$19.4M +$19.7M +71,860 New
Hudson Bay Capital Management
7
Hudson Bay Capital Management
Connecticut
$14.5M +$14.7M +53,731 New
JP Morgan Chase
8
JP Morgan Chase
New York
$13.3M +$13.5M +49,286 New
Jennison Associates
9
Jennison Associates
New York
$12.8M +$12.9M +47,205 New
Fidelity Investments
10
Fidelity Investments
Massachusetts
$12.1M +$12.3M +44,805 New
HA
11
HHLR Advisors
Cayman Islands
$10.8M +$11M +40,000 New
AMH
12
Aspex Management (HK)
Hong Kong
$7.9M +$8.02M +29,242 New
Millennium Management
13
Millennium Management
New York
$7.23M +$7.33M +26,758 New
BBA
14
Baker Bros. Advisors
New York
$6.75M +$6.85M +25,000 New
CAM
15
Cormorant Asset Management
Massachusetts
$6.75M +$6.85M +25,000 New
Ameriprise
16
Ameriprise
Minnesota
$6M +$6.09M +22,211 New
HH
17
HSG Holding
Hong Kong
$5.73M +$5.81M +21,212 New
RSCM
18
Rock Springs Capital Management
Maryland
$5.4M +$5.48M +20,000 New
PA
19
Perceptive Advisors
New York
$4.05M +$4.11M +15,000 New
RG
20
Redmile Group
California
$3.62M +$3.67M +13,393 New
GAM
21
Greenwoods Asset Management
Cayman Islands
$3.36M +$3.41M +12,451 New
CCM
22
CAAS Capital Management
New York
$1.89M +$1.92M +7,000 New
AI
23
Atom Investors
Texas
$1.57M +$1.6M +5,824 New
ECM
24
ExodusPoint Capital Management
New York
$1.5M +$1.52M +5,542 New
HP
25
Hound Partners
New York
$1.31M +$1.33M +4,840 New
1
2

BNR Hedge Fund Activity: Q2 2020 in Review

47 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q2 2020, worth a combined $426M.

Buyers outnumbered sellers: 47 funds opened new BNR positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $130M.

  • 47 institutional investors held Burning Rock Biotech (BNR) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $426M of Burning Rock Biotech stock for Q2 2020.
  • 47 funds opened new Burning Rock Biotech positions in Q2 2020 and 0 closed out, a net change of +47 holders.
  • The largest Burning Rock Biotech buyer in Q2 2020 was OrbiMed, an estimated $130M added.

Based on aggregated 13F filings for Q2 2020.